Bibliographic Citation
| - CasasnovasRene-Olivier, BouabdallahReda, BricePauline, LazaroviciJulien, GhesquieresHervé, StamatoullasAspasia, DupuisJehan, GacAnne-Claire, GastinneThomas, JolyBertrand, BouabdallahKrimo, Nicolas-VirelizierEmmanuelle, FeugierPierre, MorschhauserFranck, DelarueRichard, FarhatHassan, QuittetPhilippe, Berriolo-RiedingerAlina, TempesculAdrian, EdelineVéronique, MaisonneuveHervé, ForneckerLuc-Matthieu, LamyThierry, DelmerAlain, DartiguesPeggy, MartinLaurent, AndréMarc, MounierNicolas, Traverse-GlehenAlexandra, MeignanMichel . PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study . Lancet Oncology, 2019
- Casasnovas Rene-Olivier, Bouabdallah Reda, Brice Pauline, Lazarovici Julien, Ghesquieres Hervé, Stamatoullas Aspasia, Dupuis Jehan, Gac Anne-Claire, Gastinne Thomas, Joly Bertrand, Bouabdallah Krimo, Nicolas-Virelizier Emmanuelle, Feugier Pierre, Morschhauser Franck, Delarue Richard, Farhat Hassan, Quittet Philippe, Berriolo-Riedinger Alina, Tempescul Adrian, Edeline Véronique, Maisonneuve Hervé, Fornecker Luc-Matthieu, Lamy Thierry, Delmer Alain, Dartigues Peggy, Martin Laurent, André Marc, Mounier Nicolas, Traverse-Glehen Alexandra, Meignan Michel . PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study . Lancet Oncology, 2019
|